MiR-30a-5p regulates GLT-1 function via a PKCα-mediated ubiquitin degradation pathway in a mouse model of Parkinson’s disease

Xingjun MENG, Jianping ZHONG, Chong ZENG, Kin Lam Ken YUNG, Xiuping ZHANG, Xiaojuan WU, Shaogang QU

Research output: Contribution to journalArticlespeer-review

11 Citations (Scopus)

Abstract

Glutamate excitotoxicity is caused by dysfunctional glutamate transporters and plays an important role in the pathogenesis of Parkinson's disease (PD); however, the mechanisms that underlie the regulation of glutamate transporters in PD are still not fully elucidated. MicroRNAs(miRNA), which are abundant in astrocytes and neurons, have been reported to play key roles in regulating the translation of glutamate-transporter mRNA. In this study, we hypothesized that the miR-30a-5p contributes to the pathogenesis of PD by regulating the ubiquitin-mediated degradation of glutamate transporter 1 (GLT-1). We demonstrated that short-hairpin RNA-mediated knockdown of miR-30a-5p ameliorated motor deficits and pathological changes like astrogliosis and reactive microgliosis in a mouse model of PD (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice). Western blotting and immunofluorescent labeling revealed that miR-30a-5p suppressed the expression and function of GLT-1 in MPTP-treated mice and specifically in astrocytes treated with 1-methyl-4-phenylpyridinium (MPP+) (cell model of PD). Both in vitro and in vivo, we found that miR-30a-5p knockdown promoted glutamate uptake and increased GLT-1 expression by hindering GLT-1 ubiquitination and subsequent degradation in a PKCα-dependent manner. Therefore, we conclude that miR-30a-5p represents a potential therapeutic target for the treatment of PD. Copyright © 2021 American Chemical Society.

Original languageEnglish
Pages (from-to)1578-1592
JournalACS Chemical Neuroscience
Volume12
Issue number9
Early online dateApr 2021
DOIs
Publication statusPublished - May 2021

Citation

Meng, X., Zhong, J., Zeng, C., Yung, K. K. L., Zhang, X., Wu, X., & Qu, S. (2021). MiR-30a-5p regulates GLT-1 function via a PKCα-mediated ubiquitin degradation pathway in a mouse model of Parkinson’s disease. ACS Chemical Neuroscience, 12(9), 1578-1592. https://doi.org/10.1021/acschemneuro.1c00076

Keywords

  • Parkinson’s disease
  • miR-30a-5p
  • GLT-1
  • Ubiquitination
  • PKCα

Fingerprint

Dive into the research topics of 'MiR-30a-5p regulates GLT-1 function via a PKCα-mediated ubiquitin degradation pathway in a mouse model of Parkinson’s disease'. Together they form a unique fingerprint.